News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
500,739 Results
Type
Article (29689)
Company Profile (76)
Press Release (470974)
Multimedia
Podcasts (26)
Webinars (9)
Section
Business (147296)
Career Advice (844)
Deals (25187)
Drug Delivery (58)
Drug Development (56568)
Employer Resources (70)
FDA (13328)
Job Trends (10583)
News (247618)
Policy (23232)
Tag
2024 BioCapital Digital (4)
2024 BioForest Digital (3)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (2)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (4)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1911)
Accelerated approval (4)
Adcomms (11)
Allergies (75)
Alliances (34074)
ALS (63)
Alzheimer's disease (969)
Antibody-drug conjugate (ADC) (59)
Approvals (13390)
Artificial intelligence (182)
Autoimmune disease (11)
Automation (7)
Bankruptcy (214)
Best Places to Work (8413)
BIOSECURE Act (5)
Biosimilars (43)
Biotechnology (59)
Bladder cancer (62)
Brain cancer (21)
Breast cancer (210)
Cancer (1590)
Cardiovascular disease (126)
Career advice (738)
Career pathing (16)
CAR-T (89)
Cell therapy (255)
Cervical cancer (14)
Clinical research (47372)
Collaboration (520)
Compensation (260)
Complete response letters (9)
COVID-19 (1642)
CRISPR (17)
C-suite (179)
Cystic fibrosis (51)
Data (1667)
Decentralized trials (2)
Denatured (17)
Depression (31)
Diabetes (195)
Diagnostics (4580)
Digital health (12)
Diversity (5)
Diversity, equity & inclusion (22)
Drug discovery (66)
Drug pricing (60)
Drug shortages (21)
Duchenne muscular dystrophy (65)
Earnings (60162)
Editorial (21)
Employer branding (11)
Employer resources (68)
Events (75450)
Executive appointments (579)
FDA (14366)
Featured Employer (19)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (502)
Gene editing (47)
Generative AI (14)
Gene therapy (170)
GLP-1 (470)
Government (3221)
Grass and pollen (3)
Guidances (40)
Healthcare (14651)
Huntington's disease (12)
IgA nephropathy (18)
Immunology and inflammation (51)
Indications (22)
Infectious disease (1717)
Inflammatory bowel disease (90)
Inflation Reduction Act (6)
Influenza (26)
Intellectual property (60)
Interviews (88)
IPO (11688)
IRA (20)
Job creations (2497)
Job search strategy (674)
Kidney cancer (8)
Labor market (13)
Layoffs (246)
Leadership (8)
Legal (5081)
Liver cancer (59)
Lung cancer (241)
Lymphoma (110)
Machine learning (2)
Management (24)
Manufacturing (137)
MASH (56)
Medical device (13291)
Medtech (13295)
Mergers & acquisitions (13908)
Metabolic disorders (474)
Multiple sclerosis (59)
NASH (14)
Neurodegenerative disease (54)
Neuropsychiatric disorders (11)
Neuroscience (1334)
NextGen: Class of 2025 (4758)
Non-profit (3218)
Northern California (1834)
Now hiring (18)
Obesity (236)
Opinion (105)
Ovarian cancer (56)
Pain (65)
Pancreatic cancer (58)
Parkinson's disease (104)
Partnered (15)
Patents (123)
Patient recruitment (85)
Peanut (40)
People (45887)
Pharmaceutical (20)
Pharmacy benefit managers (11)
Phase I (13990)
Phase II (20674)
Phase III (16421)
Pipeline (884)
Policy (66)
Postmarket research (1918)
Preclinical (5013)
Press Release (68)
Prostate cancer (81)
Psychedelics (19)
Radiopharmaceuticals (190)
Rare diseases (220)
Real estate (3932)
Recruiting (24)
Regulatory (16499)
Reports (20)
Research institute (1762)
Resumes & cover letters (113)
Rett syndrome (4)
RNA editing (2)
RSV (20)
Schizophrenia (54)
Series A (79)
Series B (58)
Service/supplier (3)
Sickle cell disease (26)
Southern California (1537)
Special edition (4)
Spinal muscular atrophy (113)
Sponsored (16)
Startups (2548)
State (1)
Stomach cancer (9)
Supply chain (42)
Tariffs (13)
The Weekly (9)
United States (16194)
Vaccines (381)
Venture capitalists (14)
Weight loss (148)
Women's health (17)
Worklife (5)
Date
Today (66)
Last 7 days (489)
Last 30 days (1640)
Last 365 days (23660)
2025 (7086)
2024 (25653)
2023 (29737)
2022 (39218)
2021 (42188)
2020 (40970)
2019 (34841)
2018 (26629)
2017 (23969)
2016 (23001)
2015 (27589)
2014 (21231)
2013 (17645)
2012 (18982)
2011 (19611)
2010 (18486)
Location
Africa (481)
Alabama (25)
Alaska (4)
Arizona (136)
Arkansas (10)
Asia (29647)
Australia (4617)
California (4071)
Canada (1470)
China (396)
Colorado (196)
Connecticut (196)
Delaware (118)
Europe (61012)
Florida (653)
Georgia (140)
Idaho (44)
Illinois (412)
India (18)
Indiana (246)
Iowa (4)
Japan (142)
Kansas (81)
Kentucky (20)
Louisiana (8)
Maine (64)
Maryland (710)
Massachusetts (2984)
Michigan (156)
Minnesota (333)
Mississippi (2)
Missouri (66)
Montana (27)
Nebraska (22)
Nevada (48)
New Hampshire (60)
New Jersey (1330)
New Mexico (13)
New York (1207)
North Carolina (733)
North Dakota (5)
Northern California (1834)
Ohio (146)
Oklahoma (8)
Oregon (25)
Pennsylvania (986)
Puerto Rico (8)
Rhode Island (27)
South America (714)
South Carolina (21)
Southern California (1537)
Tennessee (85)
Texas (633)
Utah (144)
Virginia (108)
Washington D.C. (43)
Washington State (313)
West Virginia (3)
Wisconsin (47)
500,739 Results for "reverse medical corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Duchenne muscular dystrophy
Wave’s Duchenne Exon-Skipper Reverses Muscle Damage in Mid-Stage Trial
WVE-N531, an oligonucleotide, elicited significant functional benefit and reversal of muscle damage in the Phase II FORWARD-53 trial. Wave plans to file for accelerated approval of the candidate in 2026.
March 26, 2025
·
3 min read
·
Heather McKenzie
Press Releases
SFJ Pharmaceuticals & SERB Pharmaceuticals Present Positive Final Results from Pivotal Ph 3 REVERSE-IT Trial of Bentracimab for the Reversal of Antiplatelet Effects of Ticagrelor in Patients Requiring Surgery or Experiencing Major Bleeding
March 31, 2025
·
7 min read
SeaStar Medical Announces 25-for-1 Reverse Stock Split
SeaStar Medical Holding Corporation announces the Company’s 25-for-1 reverse stock split, which will become effective at June 7, 2024 at 5:00 PM EDT.
June 6, 2024
·
5 min read
Press Releases
X4 Pharmaceuticals Announces Reverse Stock Split
April 24, 2025
·
6 min read
Press Releases
Organovo Announces Reverse Stock Split
March 20, 2025
·
3 min read
Press Releases
Aptose Announces Reverse Share Split
February 19, 2025
·
5 min read
Press Releases
Virpax Pharmaceuticals Announces Reverse Stock Split
March 19, 2025
·
5 min read
Press Releases
BioXcel Therapeutics Announces Reverse Stock Split
February 6, 2025
·
6 min read
Press Releases
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics
April 14, 2025
·
5 min read
Press Releases
CNS Pharmaceuticals Announces Reverse Stock Split
February 19, 2025
·
4 min read
1 of 50,074
Next
